Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

PHRRF

PharmaTher (QB) (PHRRF)

PharmaTher Holdings Ltd (QB)
일자:
정렬 기준:
 검색 관련기사 보기:USOTC:PHRRF
일자시간출처헤드라인심볼기업
2022/09/1919:31TipRanksAnalysts Offer Insights on Healthcare Companies: PharmaTher Holdings Ltd (OtherPHRRF), Rezolute (RZLT) and ADC Therapeutics (ADCT)USOTC:PHRRFPharmaTher Holdings Ltd (QB)
2022/06/1518:03TipRanksH.C. Wainwright Keeps a Buy Rating on PharmaTher Holdings Ltd (PHRRF)USOTC:PHRRFPharmaTher Holdings Ltd (QB)
2021/11/2220:16TipRanksH.C. Wainwright Thinks NPharmaTher’s Stock is Going to RecoverUSOTC:PHRRFPharmaTher Holdings Ltd (QB)
2021/11/1200:00InvestorsHub NewsWirePharmaTher Announces Positive Research Results for Psilocybin Microneedle PatchUSOTC:PHRRFPharmaTher Holdings Ltd (QB)
2021/11/0321:03InvestorsHub NewsWirePharmaTher Enters into Research Collaboration Agreement with Revive Therapeutics for Development of Psilocybin Microneedle PatchUSOTC:PHRRFPharmaTher Holdings Ltd (QB)
2021/10/1920:07InvestorsHub NewsWirePharmaTher Engages Alcami for Clinical and Commercial Manufacturing of Novel Ketamine ProductsUSOTC:PHRRFPharmaTher Holdings Ltd (QB)
2021/10/1322:20InvestorsHub NewsWirePharmaTher Granted FDA Orphan Drug Designation For Ketamine To Treat Complex Regional Pain SyndromeUSOTC:PHRRFPharmaTher Holdings Ltd (QB)
2021/09/2123:19InvestorsHub NewsWirePharmaTher Added to the North American Psychedelics Index and First Psychedelic Exchange Traded FundUSOTC:PHRRFPharmaTher Holdings Ltd (QB)
2021/09/1322:03InvestorsHub NewsWirePharmaTher Provides Product Pipeline Updates and Anticipated Milestones for Q4-2021 and 2022USOTC:PHRRFPharmaTher Holdings Ltd (QB)
2021/08/0421:15InvestorsHub NewsWirePharmaTher Granted FDA Orphan Drug Designation For Ketamine To Treat Amyotrophic Lateral SclerosisUSOTC:PHRRFPharmaTher Holdings Ltd (QB)
2021/07/2121:19InvestorsHub NewsWirePharmaTher Expands Psychedelic Patent Portfolio with Filing of U.S. Patent Application for Novel Ketamine FormulationUSOTC:PHRRFPharmaTher Holdings Ltd (QB)
2021/06/1700:14InvestorsHub NewsWirePharmaTher Files FDA Pre-IND Meeting Request and Briefing Package For KETABET™ To Treat DepressionUSOTC:PHRRFPharmaTher Holdings Ltd (QB)
2021/05/2521:45InvestorsHub NewsWirePharmaTher Files for FDA Orphan Drug Designation for Ketamine to Treat Lou Gehrig's DiseaseUSOTC:PHRRFPharmaTher Holdings Ltd (QB)
2021/05/1721:02InvestorsHub NewsWirePharmaTher Announces FDA Approval of Ketamine IND In The Treatment of Parkinson's DiseaseUSOTC:PHRRFPharmaTher Holdings Ltd (QB)
2021/04/2720:47InvestorsHub NewsWirePharmaTher Expands Patent Portfolio with Filing of U.S. Patent Application for Ketamine and Repurposing of Psychedelics..ContUSOTC:PHRRFPharmaTher Holdings Ltd (QB)
2021/04/2021:00InvestorsHub NewsWirePharmaTher Announces Submission of IND Application with the FDA for Phase 2 Clinical TrialUSOTC:PHRRFPharmaTher Holdings Ltd (QB)
2021/04/1600:32InvestorsHub NewsWirePharmaTher Provides Update on Psychedelic Product ProgramsUSOTC:PHRRFPharmaTher Holdings Ltd (QB)
2021/03/0221:34InvestorsHub NewsWirePharmaTher Expands to Neuromuscular Diseases with Exclusive License Agreement for Ketamine in the Treatment of Lou....ContUSOTC:PHRRFPharmaTher Holdings Ltd (QB)
2021/02/1800:11InvestorsHub NewsWirePharmaTher Announces Sale of Psilocybin ProgramUSOTC:PHRRFPharmaTher Holdings Ltd (QB)
2021/02/0422:21InvestorsHub NewsWirePharmaTher Announces Successful Completion of Pre-IND Meeting with FDAUSOTC:PHRRFPharmaTher Holdings Ltd (QB)
2021/02/0122:19InvestorsHub NewsWirePharmaTher Signs Exclusive Worldwide License Agreement for Patented Microneedle Delivery Technology to Deliver KetamineUSOTC:PHRRFPharmaTher Holdings Ltd (QB)
2021/01/1922:07InvestorsHub NewsWirePharmaTher Signs Exclusive Worldwide License Agreement for Patented Ketamine FormulationUSOTC:PHRRFPharmaTher Holdings Ltd (QB)
 검색 관련기사 보기:USOTC:PHRRF